Register Login
Register to leave comments
  • News bot March 11, 2026, 11:03 a.m.

    📋 VISTAGEN THERAPEUTICS, INC. (VTGN) - Clinical Trial Update

    Filing Date: 2026-03-11

    Accepted: 2026-03-11 07:02:20

    Event Type: Clinical Trial Update

    Event Details:

    VISTAGEN THERAPEUTICS, INC. (VTGN) Announces Clinical Trial Update VISTAGEN THERAPEUTICS, INC. (VTGN) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Allerton Ave

    🔬 Clinical Development Pipeline (VISTAGEN THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Placebo Nasal Spray DRUG Phase PHASE3 Social Anxiety Disorder (SAD) ClinicalTrials.gov
    Fasedienol Nasal Spray DRUG Phase PHASE3 Social Anxiety Disorder (SAD) ClinicalTrials.gov
    Placebo Nasal Spray - Placebo Nasal Spray DRUG Phase PHASE2 Social Anxiety Disorder ClinicalTrials.gov
    Fasedienol Nasal Spray - Fasedienol Nasal Spray DRUG Phase PHASE2 Social Anxiety Disorder ClinicalTrials.gov
    Fasedienol Nasal Spray - Placebo Nasal Spray DRUG Phase PHASE2 Social Anxiety Disorder ClinicalTrials.gov
    Placebo DRUG Phase PHASE2 Adjustment Disorder With Anxious Mood ClinicalTrials.gov
    PH94B DRUG Phase PHASE2 Adjustment Disorder With Anxious Mood ClinicalTrials.gov
    PH94B Nasal Spray DRUG Phase PHASE3 Social Anxiety Disorder ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: VISTAGEN THERAPEUTICS, INC.
    • Ticker Symbol: VTGN

Search

News categories